Here are six things to know:
1. The company issued 2.3 million common shares at CDN $1.25 per share.
2. The aggregate gross proceeds are expected to reach CDN $2.9 million.
3. Aurora Spine is planning more traches of the offering on a rolling basis, hoping to amass CDN $4 million in total gross proceeds.
4. Aurora Spine paid CDN $109,600 in finders’ fees in connection with the offering to certain arm’s length finders. This amount is equal to 8 percent of the proceeds raised under the tranche offering.
5. Net proceeds will be used for general working capital purposes.
6. Director of Aurora Spine David Rosenkrantz directly or indirectly subscribed for 160,000 common shares under the initial tranche offering.
More articles on spine devices:
LDR, Amendia, Precision Spine & more—18 key notes
MIS instruments market: 7 key trends
DJO’s net loss down to $90.5M in 2014—10 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
